Antiphospholipid syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Antiphospholipid syndrome}} {{CMG}} ==Overview== ==Historical Perspective== ==References== {{reflist|2}} Category:Disease Category:Rheumatology Categ...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Antiphospholipid syndrome}}
{{Antiphospholipid syndrome}}
{{CMG}}
{{CMG}}{{AE}}{{FT}}


==Overview==
==Overview==


==Historical Perspective==
==Historical Perspective==
 
The historical perspective of antiphospholipid syndrome(APS) is as follows:<ref name="pmid16420554">{{cite journal| author=Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al.| title=International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). | journal=J Thromb Haemost | year= 2006 | volume= 4 | issue= 2 | pages= 295-306 | pmid=16420554 | doi=10.1111/j.1538-7836.2006.01753.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16420554  }} </ref><ref name="pmid20149305">{{cite journal| author=Solano C, Lamuño M, Vargas A, Amezcua-Guerra LM| title=Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome. | journal=Clin Exp Rheumatol | year= 2009 | volume= 27 | issue= 6 | pages= 914-9 | pmid=20149305 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20149305  }} </ref><ref name="pmid17337473">{{cite journal| author=Kaul M, Erkan D, Sammaritano L, Lockshin MD| title=Assessment of the 2006 revised antiphospholipid syndrome classification criteria. | journal=Ann Rheum Dis | year= 2007 | volume= 66 | issue= 7 | pages= 927-30 | pmid=17337473 | doi=10.1136/ard.2006.067314 | pmc=2497429 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17337473  }} </ref>
*In 1999, Sapporo classification criteria for APS were published in an international consensus statement in Sydney, Australia.
*In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-Beta(2)GPI antibodies in the diagnostic criteria.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 17:02, 20 March 2018

Antiphospholipid syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Antiphospholipid syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Antiphospholipid syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Antiphospholipid syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Antiphospholipid syndrome historical perspective

CDC on Antiphospholipid syndrome historical perspective

Antiphospholipid syndrome historical perspective in the news

Blogs on Antiphospholipid syndrome historical perspective

Directions to Hospitals Treating Antiphospholipid syndrome

Risk calculators and risk factors for Antiphospholipid syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]

Overview

Historical Perspective

The historical perspective of antiphospholipid syndrome(APS) is as follows:[1][2][3]

  • In 1999, Sapporo classification criteria for APS were published in an international consensus statement in Sydney, Australia.
  • In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-Beta(2)GPI antibodies in the diagnostic criteria.

References

  1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R; et al. (2006). "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)". J Thromb Haemost. 4 (2): 295–306. doi:10.1111/j.1538-7836.2006.01753.x. PMID 16420554.
  2. Solano C, Lamuño M, Vargas A, Amezcua-Guerra LM (2009). "Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome". Clin Exp Rheumatol. 27 (6): 914–9. PMID 20149305.
  3. Kaul M, Erkan D, Sammaritano L, Lockshin MD (2007). "Assessment of the 2006 revised antiphospholipid syndrome classification criteria". Ann Rheum Dis. 66 (7): 927–30. doi:10.1136/ard.2006.067314. PMC 2497429. PMID 17337473.